<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
September 29, 1998
Date of Report (Date of earliest event reported)
Arrhythmia Research Technology, Inc.
(Exact name of registrant as specified in its charter)
Delaware 1-9731 72-0925679
(State of other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
5910 Courtyard Drive, Suite 300
Austin, Texas 78731
(Address of principal executive offices)
(512) 343-6912
(Registrant's telephone number, including area code)
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Page 1 of 2
<PAGE>
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
BDO Seidman LLP has been engaged as the registrant's principal
accountant to audit the registrant's financial statements. The date of BDO
Seidman LLP's engagement was September 29, 1998.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ARRHYTHMIA RESEARCH TECHNOLOGY, INC.
Date: October 6, 1998 By: /s/ Anthony A. Cetrone
-----------------------------------
Anthony A. Cetrone, President
Page 2 of 2
